SCHEMBL4775272

SCHEMBL4775272

CCOc1cccc(C)c1C1CC1C(=O)Nc1sc2c(c1C#N)CCNC2

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.43
NPC1 O15118 7/20 0.42
RAB9A P51151 6/20 0.42
ALDH1A1 P00352 6/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 5/20 0.40
HPGD P15428 3/20 0.40
LMNA P02545 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769353 0.92 POLB (0.50) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL2895460 0.89 NPC1 (0.41) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4776039 0.88 MAPT (0.42) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4775000 0.85 ALDH1A1 (0.45) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4766163 0.85 RAB9A (0.41) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4771546 0.84 NPC1 (0.45) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4963439 0.83 ALDH1A1 (0.43) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4963443 0.83 ALDH1A1 (0.44) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4766464 0.82 POLB (0.48) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4771906 0.82 POLB (0.44) POLBNPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893618-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-05 EP disclosed
WO-2006125815-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed